ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
Therapeutic Potential of Linalool in Endometriosis: Modulation of Oxidative Stress, Inflammation, and Apoptosis in a Rat Model.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Endometriosis (EMS) is a chronic inflammatory disease affecting 10%-15% of women of reproductive age and is a major cause of infertility. This study explores the therapeutic effects of linalool, a natural compound with antioxidant and anti-inflammatory properties, on EMS in a rat model. Twenty-four female rats were divided into four groups: sham, EMS control, and two treatment groups receiving linalool at 50 mg/kg and 100 mg/kg. EMS was induced by implanting uterine tissue, and linalool was administered for 28 days. Oxidative stress markers (MDA, SOD, GPx, CAT), inflammation indicators (TNF-α, IL-1β, NF-κB), apoptosis regulators (Bax, Bcl-2, caspase-3), autophagy marker (Beclin1), adhesion molecule (ICAM-1), and angiogenic factor (VEGF) were all assessed using biochemical and histological techniques. Linalool treatment significantly reduced lesion size and oxidative stress in a dose-dependent manner. The higher dose group (Lina 100) showed nearly normal histological features tissue histology. Linalool boosted antioxidant enzymes, reduced inflammatory signaling via NF-κB and MAPK pathways, promoted apoptosis, and suppressed angiogenesis and cellular adhesion. These findings suggest that linalool exerts multi-targeted effects to reduce EMS severity. The study highlights linalool's promise as a potential therapeutic agent for EMS, though further research in human models is needed to confirm its clinical relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.